Difficulty: Medium
Average Score: 62%
Practice
If phenelzine is administered to a patient taking fluoxetine, the most likely result is
Correct answer
C
Rationale
In this scenario, the correct answer is C) Agitation, muscle rigidity, hyperthermia, seizures. The interaction between phenelzine, a monoamine oxidase inhibitor (MAOI), and fluoxetine, a selective serotonin reuptake inhibitor (SSRI), can lead to a potentially life-threatening condition known as serotonin syndrome.
Serotonin syndrome results from excessive serotonergic activity in the central nervous system and can manifest in symptoms such as agitation, muscle rigidity, hyperthermia, and seizures. When phenelzine and fluoxetine are combined, there is an increased risk of serotonin syndrome due to the additive effects on serotonin levels.
Option A) Antagonism of the antidepressant action of fluoxetine is incorrect because the interaction between these two drugs does not negate the antidepressant effects of fluoxetine.
Option B) A decrease in the plasma levels of fluoxetine is incorrect because the interaction between phenelzine and fluoxetine does not typically lead to decreased levels of fluoxetine.
Option D) Priapism is incorrect because this condition is not typically associated with the combination of phenelzine and fluoxetine.
Educationally, this question highlights the importance of understanding drug interactions, particularly when combining medications that affect similar neurotransmitter systems. It underscores the potential risks and complications that can arise from combining MAOIs and SSRIs, emphasizing the need for healthcare providers to be vigilant in monitoring for adverse effects when prescribing these medications concurrently. Understanding such interactions is crucial for safe and effective pharmacological management in clinical practice.
Serotonin syndrome results from excessive serotonergic activity in the central nervous system and can manifest in symptoms such as agitation, muscle rigidity, hyperthermia, and seizures. When phenelzine and fluoxetine are combined, there is an increased risk of serotonin syndrome due to the additive effects on serotonin levels.
Option A) Antagonism of the antidepressant action of fluoxetine is incorrect because the interaction between these two drugs does not negate the antidepressant effects of fluoxetine.
Option B) A decrease in the plasma levels of fluoxetine is incorrect because the interaction between phenelzine and fluoxetine does not typically lead to decreased levels of fluoxetine.
Option D) Priapism is incorrect because this condition is not typically associated with the combination of phenelzine and fluoxetine.
Educationally, this question highlights the importance of understanding drug interactions, particularly when combining medications that affect similar neurotransmitter systems. It underscores the potential risks and complications that can arise from combining MAOIs and SSRIs, emphasizing the need for healthcare providers to be vigilant in monitoring for adverse effects when prescribing these medications concurrently. Understanding such interactions is crucial for safe and effective pharmacological management in clinical practice.